Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
T2-Weighted Cardiovascular Magnetic Resonance and Echocardiographic Arterial Elasticity Criteria for Monitoring Cardiac Siderosis in Patients With Beta-Thalassemia Major Publisher



Zavar R1 ; Hendimarjan M1 ; Behjati M1 ; Yazdani D1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Shahid Rahmani Alley, Moshtagh Sevom St., Isfahan, Iran

Source: Journal of Research in Medical Sciences Published:2022


Abstract

Background: Despite the availability of iron chelators, toxicity due to increased iron load is the leading cause of death in thalassemia major patients, especially in Iran. This study was performed to determine the association between cardiovascular magnetic resonance using T2-weighted sequences (CMR T2∗) and diagnostic value of echocardiographic arterial elasticity in major beta-thalassemia patients without cardiac symptoms in Isfahan, Iran, in 2019 and 2021. Materials and Methods: This cross-sectional study assessed the association between CMR T2∗, advanced echocardiographic arterial elasticity criteria, and serum ferritin in 67 patients with major beta-thalassemia patients without cardiac symptoms at Chamran Cardiovascular, Medical, and Research Center in Isfahan, Iran, in 2019-2021. Data analysis was performed among the 67 patients using SPSS, version 24.0 (Statistical Procedures for Social Sciences, Chicago, Illinois, USA). Spearman's rank test was used to assess the correlation between T2∗CMR, echocardiographic arterial elasticity criteria, and ferritin. All parameters are presented as mean ± standard deviation. The results were considered statistically significant at P < 0.05. Results: There was a positive correlation between CMR T2∗ and arterial elastance index (P = 0.035, r = 0.258), according to the Spearman test. In addition, CMR T2∗ was not correlated with the serum ferritin (P = 0.158, r = 0.201). Conclusion: Totally, according to the obtained results, it may be concluded that the arterial elastance index from echocardiography and the CMR T2∗ may be indicators of myocardial iron overload in patients with major beta-thalassemia patients without cardiac symptoms. © 2022 Wolters Kluwer Medknow Publications. All rights reserved.
Related Docs
View other Related Docs
1. Correlation of N-Terminal Pro-B-Type Natriuretic Peptide Levels and Cardiac Magnetic Resonance Imaging T2∗ in Patients With Β-Thalassaemia Major, Blood Transfusion (2016)
2. Correlation Between Myocardial Iron Overload Detected by Cmrt2∗ and Left Ventricular Function Assessed by Tissue Doppler Imaging in Patients With Thalassemia Major, Journal of Cardiovascular Echography (2022)
3. The Correlation Between the Cardiac and Hepatic Iron-Overload in Patients With Thalassemia Major Who Received Multiple Transfusion, Journal of Isfahan Medical School (2010)
4. Comparison of Iron Chelation Effects of Deferoxamine, Deferasirox, and Combination of Deferoxamine and Deferiprone on Liver and Cardiac T2* Mri in Thalassemia Maior, Caspian Journal of Internal Medicine (2017)
5. The Effect of Combination Iron Chelating Agents on Reducing the Severity Grading of Heart and Liver Iron Overload in Β-Thalassemia Patients, Iranian Journal of Pediatric Hematology and Oncology (2019)
6. Assessment of the Relationship Between Iron Overload Based on Cardiac T2* Mri and Fragmented Qrs in Beta-Thalassemia Major Patients, Shiraz E Medical Journal (2020)
7. The Relation Between Body Iron Store and Ferritin, and Coronary Artery Disease, ARYA Atherosclerosis (2014)
8. Association of Body Mass Index and Serum Ferritin Level in Pediatrics With Beta-Thalassemia Major Disease, Iranian Journal of Pediatric Hematology and Oncology (2022)
Experts (# of related papers)
View all Related Experts
Mohammad Reza Maracy (4)
Majid Ghanavat (2)
Other Related Docs
9. Influence of Average Annual Mean Serum Ferritin Levels on Left Ventricular Function in Patients With Β Thalassemia, Acta Medica Iranica (2020)
10. Evaluation of Iron Status by Serum Ferritin Level in Iranian Carriers of Beta Thalassemia Minor, International Journal for Vitamin and Nutrition Research (2008)
11. Hypercoagulopathy and Serum “Natural Antithrombotic Factors” in Beta-Thalassemia Major, Journal of Isfahan Medical School (2008)
12. Efficacy and Safety of Iranian Made Deferasirox (Osveral®)In Iranian Major Thalassemic Patients With Transfusional Iron Overload: A One Year Prospective Multicentric Open-Label Non-Comparative Study, DARU, Journal of Pharmaceutical Sciences (2011)
13. An Evaluation of Sensory Neural Hearing Loss in Thalassaemic Patients Treated With Desferrioxamine and Its Risk Factors, Journal of Research in Medical Sciences (2005)
14. Combined Therapy of Silymarin and Desferrioxamine in Patients With Β-Thalassemia Major: A Randomized Double-Blind Clinical Trial, Fundamental and Clinical Pharmacology (2009)
15. Beneficial Effects of the Treatment of Iron Deficiency on Clinical Condition, Left Ventricular Function, and Quality of Life in Patients With Chronic Heart Failure, Acta Biomedica (2018)
16. Magnetic Resonance Imaging Signal Reduction May Precede Volume Loss in the Pituitary Gland of Transfusion-Dependent Beta-Thalassemic Patients, Acta Radiologica (2010)
17. Effectiveness of Twice Weekly Iron Supplementation Compared With Daily Regimen in Reducing Anemia and Iron Deficiency During Pregnancy: A Randomized Trial in Iran, Journal of Research in Medical Sciences (2008)
18. Double-Faced Cell-Mediated Immunity in Β-Thalassemia Major: Stimulated Phenotype Versus Suppressed Activity, Annals of Hematology (2009)
19. Cardiomyopathy in Thalassemia: Quick Review From Cellular Aspects to Diagnosis and Current Treatments, Lab Medicine (2020)
20. A Randomized Double-Blind, Placebo-Controlled Study of Therapeutic Effects of Silymarin in Β-Thalassemia Major Patients Receiving Desferrioxamine, European Journal of Haematology (2013)
21. Biochemical Parameters of Iron Metabolism and Tg/Hdl-C Ratio in Patients With Coronary Artery Disease, Journal of Isfahan Medical School (2011)
22. Chmmotv1 - Cardiac and Hepatic Multi-Echo (T2*) Mri Images and Clinical Dataset for Iron Overload on Thalassemia Patients, BMC Research Notes (2023)
23. Evaluation of the Prevalence and Determinants of Iron Deficiency Anemia in a Sample of Preschool-Aged Children in Isfahan City, Iran, Journal of Isfahan Medical School (2017)
24. Therapeutic Effects of Deferoxamine and Silymarin Versus Deferoxamine Alone in Β-Thalassemia Major Based on Findings of Liver Mri, Journal of Research in Medical Sciences (2012)